BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Querfeld U, Schaefer F. Cardiovascular risk factors in children on dialysis: an update. Pediatr Nephrol 2020;35:41-57. [DOI: 10.1007/s00467-018-4125-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 García-Bello JA, Gómez-Díaz RA, Contreras-Rodríguez A, Sánchez-Barbosa L, Mondragón-González R, Gallardo-Montoya JM, Wacher NH. Endothelial dysfunction in children with chronic kidney disease. Nefrologia 2021;41:436-45. [PMID: 33602566 DOI: 10.1016/j.nefro.2020.10.008] [Reference Citation Analysis]
2 Kouri AM, Rheault MN. Cardiovascular disease in children with chronic kidney disease. Curr Opin Nephrol Hypertens 2021;30:231-6. [PMID: 33464005 DOI: 10.1097/MNH.0000000000000684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Haffner D, Leifheit-Nestler M. Treatment of hyperphosphatemia: the dangers of aiming for normal PTH levels. Pediatr Nephrol 2020;35:485-91. [PMID: 31823044 DOI: 10.1007/s00467-019-04399-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Masuda T, Hamasaki Y, Kubota M, Hashimoto J, Takahashi Y, Muramatsu M, Takatsuki S, Matsuura H, Sakai K, Shishido S. Changes in cardiac function after renal transplantation in children: Significance of pre‐transplantation left ventricular hypertrophy. Pediatr Transplant 2019;23. [DOI: 10.1111/petr.13558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 García-bello JA, Gómez-díaz RA, Contreras-rodríguez A, Sánchez-barbosa L, Mondragón-gonzález R, Gallardo-montoya JM, Wacher NH. Endothelial dysfunction in children with chronic kidney disease. Nefrología (English Edition) 2021;41:436-45. [DOI: 10.1016/j.nefroe.2020.10.002] [Reference Citation Analysis]
6 Nguyen-Yamamoto L, Tanaka KI, St-Arnaud R, Goltzman D. Vitamin D-regulated osteocytic sclerostin and BMP2 modulate uremic extraskeletal calcification. JCI Insight 2019;4:126467. [PMID: 31292298 DOI: 10.1172/jci.insight.126467] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
7 Skrzypczyk P, Okarska-Napierała M, Pietrzak R, Pawlik K, Waścińska K, Werner B, Pańczyk-Tomaszewska M. NT-proBNP as a Potential Marker of Cardiovascular Damage in Children with Chronic Kidney Disease. J Clin Med 2021;10:4344. [PMID: 34640365 DOI: 10.3390/jcm10194344] [Reference Citation Analysis]
8 Querfeld U. Cardiovascular disease in childhood and adolescence: Lessons from children with chronic kidney disease. Acta Paediatr 2021;110:1125-31. [PMID: 33080082 DOI: 10.1111/apa.15630] [Reference Citation Analysis]